T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2B |
| 2 |
Sea Limited
SE
|
+$1.34B |
| 3 |
Morgan Stanley
MS
|
+$1.23B |
| 4 |
Incyte
INCY
|
+$1.05B |
| 5 |
Ross Stores
ROST
|
+$968M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.05B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.5B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
JPMorgan Chase
JPM
|
+$1.13B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 17.6% |
| 3 | Consumer Discretionary | 14.37% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Imunon
IMNN
$6.64M
| $224K | ﹤0.01% |
308
| – | – |
|
|
KE
2327
Kimball Electronics
KE
$626M
| $224K | ﹤0.01% |
16,513
-2,190
| -12% | -$28.2K |
|
2328
STAAR Surgical
STAA
$1.26B
| $224K | ﹤0.01% |
+3,647
| New | +$149K |
|
2329
Northrim BanCorp
NRIM
$601M
| $223K | ﹤0.01% |
35,496
+168
| +0.5% | +$975 |
|
|
VCRA
2330
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $222K | ﹤0.01% |
10,488
+170
| +2% | +$3.33K |
|
2331
Stewart Information Services
STC
$2.07B
| $220K | ﹤0.01% |
6,778
-10,804
| -61% | -$325K |
|
|
HIBB
2332
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $219K | ﹤0.01% |
+10,435
| New | +$174K |
|
2333
BCE
BCE
$21.7B
| $216K | ﹤0.01% |
5,204
+4
| +0.1% | +$165 |
|
|
ADMS
2334
DELISTED
Adamas Pharmaceuticals
ADMS
| $216K | ﹤0.01% |
84,300
-1,439
| -2% | -$4.23K |
|
2335
Hanmi Financial
HAFC
$963M
| $215K | ﹤0.01% |
22,162
+184
| +0.8% | +$1.81K |
|
|
ADXS
2336
DELISTED
Advaxis Inc
ADXS
| $215K | ﹤0.01% |
400,448
| – | – |
|
2337
Ramaco Resources Class A
METC
$667M
| $214K | ﹤0.01% |
103,364
-39,133
| -27% | -$92.7K |
|
2338
United Parks & Resorts
PRKS
$2.04B
| $213K | ﹤0.01% |
14,369
-2,173
| -13% | -$32K |
|
2339
Caleres
CAL
$461M
| $212K | ﹤0.01% |
25,431
+1
| +0% | +$7 |
|
|
DEA
2340
Easterly Government Properties
DEA
$1.18B
| $212K | ﹤0.01% |
3,660
-1,825
| -33% | -$116K |
|
|
PBIP
2341
DELISTED
Prudential Bancorp, Inc.
PBIP
| $212K | ﹤0.01% |
17,637
| – | – |
|
2342
Range Resources
RRC
$9.33B
| $211K | ﹤0.01% |
37,495
-65,026
| -63% | -$361K |
|
2343
Rockwell Medical
RMTI
$30.9M
| $209K | ﹤0.01% |
977
-216
| -18% | -$51K |
|
|
AAIC
2344
DELISTED
Arlington Asset Investment Corp.
AAIC
| $204K | ﹤0.01% |
68,575
+1
| +0% | +$3 |
|
2345
Inogen
INGN
$154M
| $203K | ﹤0.01% |
5,712
-122,908
| -96% | -$5.18M |
|
|
FLXN
2346
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $203K | ﹤0.01% |
15,413
+211
| +1% | +$2.19K |
|
2347
Lightpath Technologies
LPTH
$824M
| $202K | ﹤0.01% |
60,600
+14,400
| +31% | +$32.8K |
|
2348
Skywest
SKYW
$4.21B
| $202K | ﹤0.01% |
6,190
-7,214
| -54% | -$213K |
|
|
MNTV
2349
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $202K | ﹤0.01% |
8,599
-18,089
| -68% | -$330K |
|
|
PFBI
2350
DELISTED
Premier Financial Bancorp
PFBI
| $202K | ﹤0.01% |
15,767
| – | – |
|
Similar funds
T. Rowe Price Associates's Q2 2020 Portfolio in Review
As of Q2 2020, T. Rowe Price Associates held 2,591 positions worth $795B, up 26% from $632B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
T. Rowe Price Associates's Q2 2020 filing shows 79 new, 1,096 increased, 1,255 reduced and 100 closed positions. Its largest new stake was Vroom Inc: 200,362 shares worth $797M. The largest sale was Boeing, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2020 buy was Vroom Inc: 200,362 shares worth $797M.
- T. Rowe Price Associates added most to Microsoft in Q2 2020, an estimated $2B increase.
- T. Rowe Price Associates's biggest Q2 2020 reduction was Boeing, cutting an estimated $2.05B.
- T. Rowe Price Associates fully exited Raytheon Company in Q2 2020, selling an estimated $1.01B.
- T. Rowe Price Associates's ten largest holdings make up 25% of its $795B portfolio in Q2 2020.
- T. Rowe Price Associates opened 79 new positions and closed 100 in Q2 2020.
- T. Rowe Price Associates's portfolio value rose 26% quarter-over-quarter to $795B.
Based on T. Rowe Price Associates's 13F filing for Q2 2020, filed 14 Aug 2020.